CAS: 133242-30-5; [(4S)-2,2-Dimethyl-1,3-Dioxolan-4-Yl]Methyl 3-[4-[(2S)-2-Hydroxy-3-[2-(Morpholine-4-Carbonylamino)Ethylamino]Propoxy]Phenyl]Propanoate

该化合物是一种选择性的乙型-1肾上腺激素对抗物,主要用于临床环境,用于快速发作和短期行动,适合治疗心肌梗塞和高血压等急性病症,其特点是能够有选择地抑制心脏中的乙型-1受体,导致心率下降和心肌萎缩,而不会显著影响乙型-2受体,因为乙型-2受体是支气支气消化的.这种选择性对呼吸问题病人特别有益,因为它会最大限度地减少潜在的支气管限制.Landiolol一般通过静脉注射进行,因为其药理皮肤特征允许对剂量进行快速调整,以达到预期的治疗效果.其化学结构包括一个助产其药理特性的乳房中心.该物质一般都受到良好的调控,其副作用与其他乙型阻体相似,包括潜在的胸腔和低血压.

结构式图片

MSDS等安全信息

    上下游产品

    CAS号154467-16-0 N-(2-氨基乙基)-4-吗啉... | CAS号69630-16-6 N-(2-aminoethyl... | CAS号144256-11-1 (S)-(2,2-二甲基-1,... | CAS号501-97-3 对羟基苯丙酸 | CAS号23735-43-5 (S)-(+)-2,2-二甲基... | CAS号144481-98-1 盐酸兰地洛尔

    合成工艺路线路线简述

    • 合成目标产物 Landiolol 主要起始原料 1398109-46-0 And N-(2-Aminoethyl)Morpholine-4-Carboxamide Oxalate
    • (文献来源)合成步骤主要原料 1398109-46-0 和 N-(2-Aminoethyl)Morpholine-4-Carboxamide Oxalate
    📜2,2-Dimethyl-1,3-Dioxolan-4S-Ylmethyl 3-<4-<2(S),3-Epoxypropoxy>Phenyl>Propionate置于三乙胺体系中,用 乙腈 用作溶剂,化学反应生成兰地洛尔
    参考文献:一种制备盐酸兰地洛尔的方法
    标题:一种制备盐酸兰地洛尔的方法
    摘要:本发明属于医药化工领域,更为具体地说是涉及一种制备兰地洛尔及式8化合物的改良方法.即由通式7化合物与ah(有机胺)反应制得式8化合物.本发明还涉及通式7化合物.

    海关参考信息

    专利信息


    专利号:US-9353057-B2
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
    权利人:XENOPORT INC
    摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

    专利号:US-2008287407-A1
    优先权日:2003-12-10
    标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
    发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

    专利号:US-2015158809-A9
    优先权日:2013-02-26
    标 题 :Method of making 1-(acyloxy)-alkyl carbamate compounds
    发明人:WANG HUAN; LIU PENG; DAI QUNYING; YIN HAO; RAILLARD STEPHEN P
    权利人:XENOPORT INC
    摘要:Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.

    专利号:WO-2009094569-A2
    优先权日:2008-01-25
    标 题:Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates

    专利号:US-2005222431-A1
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof

    专利号:US-7227028-B2
    优先权日:2003-12-30
    标题 :Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Okajima M, Takamura M, Taniguchi T. Landiolol, an ultra-short-acting β1-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis. World J Crit Care Med. 2015 Aug 4;4(3):251-7. doi: 10.5492/wjccm.v4.i3.251. eCollection 2015 Aug 4.
    2: Xiao J, He P, Zou Q, Zhao Y, Xue Z, Deng X, Li S, Guo Q, Tao G, Yang T, Lang Z, He J, Wang X. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Anesth. 2015 Mar;27(2):120-8. doi: 10.1016/j.jclinane.2014.07.003. Epub 2014 Nov 28. doi: 10.1007/s00540-014-1908-5. Epub 2014 Sep 4. Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study. Adv Ther. 2014 Apr;31(4):426-39. doi: 10.1007/s12325-014-0111-2. Epub 2014 Mar 19. Erratum in: Adv Ther. 2014 May;31(5):577-8.
    5: Ishigaki D, Arimoto T, Iwayama T, Hashimoto N, Kutsuzawa D, Kumagai Y, Nishiyama S, Takahashi H, Shishido T, Miyamoto T, Watanabe T, Kubota I. Prevention of immediate recurrence of atrial fibrillation with low-dose landiolol after radiofrequency catheter ablation. J Arrhythm. 2015 Oct;31(5):279-85. doi: 10.1016/j.joa.2015.02.003. Epub 2015 Apr 4.

    合成参考文献


    参考文献:10.1007/s00540-010-0889-2
    摘要:Shiotsuka J, Sanui M, Lefor A. Safe use of landiolol hydrochloride in a patient with marked pseudocholinesterase deficiency. Journal of Anesthesia. 2010 Feb 13;24(2):309–10. doi: 10.1007/s00540-010-0889-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知